Given the tumor-promoting role of CD109 and of IL-6 in SCC and the recent findings that CD109 potentiates JAK/STAT3 signaling in lung adenocarcinoma and glioblastoma cells, it was important to establish whether CD109 regulates IL6Rα signaling in SCC and determine the mechanisms involved. This evidence concerns the gene IL6R and lung adenocarcinoma.